应用新标准提高CEUS LI-RADS 2017对HCC与非HCC恶性肿瘤的鉴别诊断效能
本研究纳入315个肝脏结节,评估CEUS LI-RADS 2017的诊断效能,并通过调整早期廓清起始时间(<45 s)和显著廓清时间(3 min内)探索改进方案。结果显示LR-5诊断HCC的敏感度在调整显著廓清时间后提高至80%且PPV和特异度无显著变化,LR-M诊断非HCC恶性肿瘤的特异度在重新分类后提高至87.5%而敏感度无显著下降。
要点
- CEUS LI-RADS 2017对HCC诊断置信度高,但易将HCC误诊为非HCC恶性肿瘤。
- 将显著廓清时间调整至3 min内重新分类LR-M,可减少HCC被误判为非HCC恶性肿瘤。
- 早期廓清起始时间调整为<45 s提高LR-5敏感度但降低特异度,需权衡利弊。
核心结论
- CEUS LI-RADS 2017对HCC诊断有良好置信度,但倾向于将HCC误诊为非HCC恶性肿瘤。
- 将显著廓清时间限定在3 min内重新分类LR-M结节可降低这种误诊可能性。
研究设计与样本
- 回顾性研究,共纳入315个肝脏结节,按CEUS LI-RADS 2017分类为LR-1至LR-5、LR-M和LR-TIV。
- 通过调整早期廓清起始时间(<45 s)和显著廓清时间(3 min内)应用新标准,将两个LR-M亚组重新分类为LR-5。
- 以病理或影像随访为参考标准,计算准确率、敏感度、特异度、PPV和NPV评估诊断效能。
诊断标准与关键数值
- 调整早期廓清起始时间至<45 s后,LR-5诊断HCC的敏感度为74.1% vs 56.1%(P<0.001),PPV为93.3% vs 96.1%(P=0.267),特异度为48.3% vs 78.5%(P=0.018)。
- 调整早期廓清起始时间至<45 s后,LR-M诊断非HCC恶性肿瘤的特异度为89.2% vs 66.2%(P<0.001),敏感度为31.5% vs 68.4%(P=0.023)。
- 按显著廓清时间重新分类后,LR-5诊断HCC的敏感度为80% vs 56.1%(P<0.001),PPV为94.9% vs 96.1%(P=0.626),特异度为80% vs 78.5%(P=0.879)。
- 重新分类的LR-M结节诊断非HCC恶性肿瘤的特异度为87.5% vs 66.2%(P<0.001),敏感度为47.3% vs 68.4%(P=0.189)。
临床应用与阅片要点
- 日常阅片使用CEUS LI-RADS 2017时需警惕将HCC误判为非HCC恶性肿瘤的风险。
- 对LR-M结节应关注显著廓清是否在3 min内发生,符合条件者可考虑重新分类为LR-5以减少误诊。
- 调整早期廓清起始时间至<45 s虽提高LR-5敏感度但降低特异度,需结合临床权衡。
局限性
- 单中心研究,样本量315个结节,结论需多中心验证。
- 回顾性设计可能存在选择偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: Using contrast-enhanced ultrasound (CEUS) to evaluate the diagnostic performance of liver imaging reporting and data system (LI-RADS) version 2017 and to explore potential ways to improve the efficacy.
METHODS: A total of 315 nodules were classified as LR-1 to LR-5, LR-M, and LR-TIV. New criteria were applied by adjusting the early washout onset (< 45 s) and the time of marked washout (within 3 min). Two subgroups of the LR-M nodules were recategorized as LR-5, respectively. The diagnostic performance was evaluated by calculating the accuracy, sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV).
RESULTS: By adjusting early washout onset to < 45 s, the LR-5 as a standard for diagnosing HCC had an improved sensitivity (74.1% vs. 56.1%, P < 0.001) without significant change in PPV (93.3% vs. 96.1%, P = 0.267), but the specificity was decreased (48.3% vs. 78.5%, P = 0.018). The LR-M as a standard for the diagnosis of non-HCC malignancies had an increase in specificity (89.2% vs. 66.2%, P < 0.001) but a decrease in sensitivity (31.5% vs. 68.4%, P = 0.023). After reclassification according to the time of marked washout, the sensitivity of the LR-5 increased (80% vs. 56.1%, P < 0.001) without a change in PPV (94.9% vs. 96.1%, P = 0.626) and specificity (80% vs. 78.5%, P = 0.879). For reclassified LR-M nodules, the specificity increased (87.5% versus 66.2%, P < 0.001) with a non-significant decrease in sensitivity (47.3% vs. 68.4%, P = 0.189).
CONCLUSIONS: The CEUS LI-RADS showed good confidence in diagnosing HCC while tended to misdiagnose HCC as non-HCC malignancies. Adjusting the marked washout time within 3 min would reduce the possibility of this misdiagnosis.
引用
- Zeng D, Xu M, Liang JY, et al. Using new criteria to improve the differentiation between HCC and non-HCC malignancies: clinical practice and discussion in CEUS LI-RADS 2017. Radiol Med. 2021. PMID: 34665430. doi:10.1007/s11547-021-01417-w
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。